Peijia Medical Limited (HKG:9996)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.91
+0.11 (1.90%)
Mar 10, 2026, 10:54 AM HKT
22.11%
Market Cap 3.88B
Revenue (ttm) 731.61M
Net Income (ttm) -246.75M
Shares Out 669.28M
EPS (ttm) -0.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 141,000
Average Volume 589,950
Open 5.80
Previous Close 5.80
Day's Range 5.80 - 6.01
52-Week Range 4.02 - 9.36
Beta 0.57
RSI 41.06
Earnings Date Mar 25, 2026

About Peijia Medical

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products include transcatheter aortic valve replacement (TAVR) systems, crosslinked dry-tissue and polymeric tri leaflet TAVR systems, transcatheter aortic valve s... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 1,035
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9996
Full Company Profile

Financial Performance

In 2024, Peijia Medical's revenue was 615.48 million, an increase of 39.53% compared to the previous year's 441.13 million. Losses were -226.58 million, -42.28% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.